Bionik Laboratories Financials
We suggest to use Bionik Laboratories Corp fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Bionik Laboratories Corp is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to collect data for thirty-three available fundamental indicators for Bionik Laboratories Corp, which can be compared to its peers.
Bionik |
Understanding current and past Bionik Laboratories Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bionik Laboratories' financial statements are interrelated, with each one affecting the others. For example, an increase in Bionik Laboratories' assets may result in an increase in income on the income statement.
Bionik Laboratories Stock Summary
Bionik Laboratories competes with Brainsway, Venus Concept, Tactile Systems, Icecure Medical, and SurModics. Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts. BIONIK LABORATORIES operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 12 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US09074A2087 |
| Business Address | 80 Coolidge Hill |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bioniklabs.com |
| Phone | 617 926 4800 |
| Currency | USD - US Dollar |
Bionik Laboratories Key Financial Ratios
There are many critical financial ratios that Bionik Laboratories' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bionik Laboratories Corp reports annually and quarterly.| Return On Equity | -7.83 | |||
| Return On Asset | -0.64 | |||
| Number Of Employees | 12 | |||
| Beta | -1.02 | |||
| Z Score | -4.6 |
Bionik Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bionik Laboratories's current stock value. Our valuation model uses many indicators to compare Bionik Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bionik Laboratories competition to find correlations between indicators driving Bionik Laboratories's intrinsic value. More Info.Bionik Laboratories Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bionik Laboratories' earnings, one of the primary drivers of an investment's value.Bionik Laboratories Corp Systematic Risk
Bionik Laboratories' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bionik Laboratories volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Bionik Laboratories Corp correlated with the market. If Beta is less than 0 Bionik Laboratories generally moves in the opposite direction as compared to the market. If Bionik Laboratories Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bionik Laboratories Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bionik Laboratories is generally in the same direction as the market. If Beta > 1 Bionik Laboratories moves generally in the same direction as, but more than the movement of the benchmark.
Other Information on Investing in Bionik Pink Sheet
Bionik Laboratories financial ratios help investors to determine whether Bionik Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bionik with respect to the benefits of owning Bionik Laboratories security.